Skip to content
OpenCapital
Get started

Limoneira LMNR Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$23.9M-31.9%
Gross profit$768.0K-77.5%
Operating income-$21.7M-549%
Net income-$21.4M-537%
EPS (diluted)-$1.20-500%

Balance sheet

See full
Cash & equivalents$891.0K-57.2%
Total debt$99.2M+72.0%
Total equity$152.9M-16.3%
Total assets$293.8M-0.9%

Cash flow

See full
Operating cash flow-$4.5M—
CapEx$880.0K+95.1%
Free cash flow-$4.3M—

Valuation

See full
Market cap$238.07M-17.7%
Enterprise value$336.42M-2.5%
P/S1.8×+0.2×

Profitability

See full
Gross margin8.5%—
Operating margin-33.2%-34.7pp
Net margin-30.5%—
FCF margin7.8%—

Returns & leverage

See full
Return on equity-24.1%—
Debt / equity0.6×+0.3×
Current ratio1.7×+0.6×